DCHFA finances 108 new affordable apartments in Columbia Heights

Washington, D.C., Aug. 01, 2025 (GLOBE NEWSWIRE) — Washington, D.C. – On July 29, 2025 the District of Columbia Housing Finance Agency (DCHFA) issued $48.26 million in tax exempt bonds, underwrote $34.9 million in federal and $6.8 million in DC Low Income Housing Tax Credit equity for the construction of Harvard Court Apartments (1425 Harvard […]

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

(NYSE MKT:MLSS), ROSELAND, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Eric C. Hines as Chief Executive Officer, effective immediately. Mr. Hines brings more than 25 years of leadership experience in scaling

Stran & Company to Announce Second Quarter 2025 Financial Results and Business Update Conference Call

(NASDAQ:SWAG),(NASDAQ:SWAGW),(Boerse Frankfurt – Freiverkehr:S9H), Quincy, MA, Aug. 01, 2025 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced it will release the Company's financial results for the second quarter 2025 after the

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma

(NASDAQ:ALLO), Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related Death in the FCA (FC plus ALLO-647) Lymphodepletion Arm Unplanned Review of Safety and Biomarker Data with Standard FC and Cema-cel Indicates Encouraging MRD Conversion Rate and

IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results

(NasdaqGM:IRMD), Announces Regular Quarterly Cash Dividend of $0.17 Per Share Raises Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $20.4 million for the second quarter of 2025, an increase of $2.5 million, or 14%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.45 and non-GAAP diluted EPS

SecureTech Announces Uplisting to OTCQB Venture Market

(Other OTC:SCTH),(OTC US:SCTH), Roseville, Minnesota, Aug. 01, 2025 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTCQB: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, is pleased to announce that its common stock has been approved for trading on the OTCQB(R) Venture Market, effective immediately. The

The North West Company Inc. Announces Appointment of Gregg Saretsky as a Director

(TSX:NWC), WINNIPEG, Manitoba, Aug. 01, 2025 (GLOBE NEWSWIRE) — The North West Company Inc. (“North West“) is pleased to announce the appointment of Gregg Saretsky as a director of North West, effective today. Gregg Saretsky is a seasoned corporate director with deep experience in the global aviation industry. He currently serves on the board of

Empro Group Inc. Announces Closing of Remaining Portion of the Underwriter’s Over-Allotment Option in Connection with its Upsized Initial Public Offering

(NasdaqGM:EMPG), Selangor, Malaysia, Aug. 01, 2025 (GLOBE NEWSWIRE) — Empro Group Inc. (the “Company” or “EMPG”), a rising beauty and personal care brand headquartered in Malaysia, today announced that it closed the sales of an additional 91,250 ordinary shares of the Company, representing the exercise of the remaining portion of the underwriter's over-allotment option granted

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

(NASDAQ:NXL),(NASDAQ:NXLIW), HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS(TM)) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025. Mr. Van Fleet brings more than 20 years

FitLife Brands Announces Second Quarter Earnings Call

FitLife Brands Announces Second Quarter Earnings Call GlobeNewswire August 01, 2025 OMAHA, NE, Aug. 01, 2025 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the second quarter of fiscal

Scroll to Top